Join the fight to end the world's deadliest and most curable infectious disease

Why invest in ending tuberculosis and lung disease?

Tuberculosis (TB) kills over 1.2 million people every year – one life every 30 seconds.

It is the world's deadliest infectious disease. And yet, it is fully treatable, curable and avoidable. And we know exactly how to stop them.

The Union has dedicated over 100 years to developing, testing, and deploying pioneering tools and systems needed to eradicate TB.

How we work: KNOW. SHARE. ACT.

We believe in a future where every healthcare worker on the frontline is equipped with the right skills, knowledge and tools to fight TB and lung disease, no matter where they are.

Our model is simple, proven, and designed for impact that lasts long after the funding ends.

KNOW – We don’t guess what works, we prove it.

We challenge outdated protocols and conduct extensive research to ensure our knowledge about TB and lung disease is backed by hard evidence.

SHARE – We empower local experts, rather than replace them.

We share evidence globally with policy makers and frontline healthcare workers, so world-class care is accessible to all.

ACT – We build systems, not parallel structures.

We take action where it is needed most, supporting countries to implement solutions that strengthen their own health systems from within.

Our impact at a glance

23,000+

healthcare professionals trained globally on TB care and prevention from 2020-2025

32,000+

children saved from TB, across eight African countries from 2021-2025

23,500+

delegates attended the Union World Conference on Lung Health from 2020-2025

Partner with impact

Our strategy to eliminate TB is evidence-backed and achievable, but we cannot do it alone. We are seeking collaborators who share our vision to create sustainable healthcare systems, build resilient communities, and save millions of lives.

We work closely with partners to understand their philanthropic priorities and match their investments to programmes where they can have the greatest impact. Maximising every dollar and creating a legacy of healthier, stronger and more equal communities.

Whether your interest lies in advocacy, innovation, or direct intervention, we can design tailored, flexible strategic packages that allow you to support transformative TB and lung health work – while advancing your broader philanthropic goals.

Collective support

The Union is uniquely positioned at the convergence of global science, advocacy and frontline action for lung health, serving as a critical lifeline for high-burden, underserved communities.

Now, with international funding streams for tuberculosis and lung disease diminishing – putting decades of progress and lifesaving innovations at risk – the need for support from corporate organisations, with a strong moral compass, has never been greater.

In this context, The Union has established a transformative united funding mechanism, inviting forward-thinking corporations to become allies in a movement dedicated to saving lives, advancing science and ensuring health equity worldwide.

Rather than restricting support to siloed projects, this unified fund enables The Union to direct investments to where they are needed most – while still granting corporate donors the freedom to allocate part or all of their contribution according to their priorities.

Whether an organisation is passionate about building health workforce capacity, advancing scientific discovery, elevating global dialogue or driving policy change, this offers a transparent pathway for tailored contribution and collective impact.

Want to join the fight?

If so, we would be delighted to share more about our vision, impact and how you can
make a difference.

Get in touch with us